RARE vs VIRT · rev $560.2M vs P/E 13, rev $2.88B
Ultragenyx (RARE) versus Virtu Financial, Inc. (VIRT) — a side-by-side from cached financials, not a winner call.
Ultragenyx (RARE) is a biotechnology company listed on US.
Virtu Financial, Inc. (VIRT) is a capital markets company listed on US.
Latest reported RARE revenue for 2024-12-31 was $560.2M. Net income was -$569.2M. Revenue was up 29.0% from 2023-12-31 to 2024-12-31. RARE currently screens at market cap $2.79B.
Latest reported VIRT revenue for 2024-12-31 was $2.88B. Net income was $534.5M. Revenue was up 25.4% from 2023-12-31 to 2024-12-31. VIRT currently screens at market cap $6.78B and trailing P/E 12.7.
RARE currently screens at market cap $2.79B. VIRT currently screens at market cap $6.78B and trailing P/E 12.7.
Not investment advice. Open the RARE and VIRT stock pages for the full models.
Not investment advice.